Literature DB >> 2018069

Clinical screening score for the fragile X (Martin-Bell) syndrome.

S Laing1, M Partington, H Robinson, G Turner.   

Abstract

A clinical score based on the manifestations of the fragile(X) syndrome has been formulated and applied to all individuals included in a fragile(X) case finding program in New South Wales. The total score can vary from 0 to 10. Individuals are scored 0, 1, or 2 in each of 5 categories considered indicative of the fragile(X) phenotype: family history of intellectual handicap, face length, ear configuration, personality, and body habitus. In a study of 1,206 individuals where the clinical scores were prospective (i.e., they had been given before the cytogenetic results were known) the percentage of those with the fragile(X) increased from 0.6% of those with scores of 4 or less to 14.6% with scores 5-7 and to 67% of those with scores 8-10. We have found the score simple to use in the circumstances where screening takes place (sheltered workshops and schools) and have reduced the number of individuals tested cytogenetically by 45%.

Entities:  

Mesh:

Year:  1991        PMID: 2018069     DOI: 10.1002/ajmg.1320380219

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

Review 1.  Investigation of children with "developmental delay".

Authors:  Louise Hartley; Alison Salt; Jon Dorling; Paul Gringras
Journal:  West J Med       Date:  2002-01

2.  Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group.

Authors:  B B de Vries; A M van den Ouweland; S Mohkamsing; H J Duivenvoorden; E Mol; K Gelsema; M van Rijn; D J Halley; L A Sandkuijl; B A Oostra; A Tibben; M F Niermeijer
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

3.  Don't miss patients with atypical FMR1 mutations: dysmorphism and clinical features in a boy with a partially methylated FMR1 full mutation.

Authors:  Edda Haberlandt; Sibylle Zotter; Martina Witsch-Baumgartner; Johannes Zschocke; Dieter Kotzot
Journal:  Eur J Pediatr       Date:  2014-07-17       Impact factor: 3.183

4.  Fragile X syndrome is less common than previously estimated.

Authors:  J E Morton; S Bundey; T P Webb; F MacDonald; P M Rindl; S Bullock
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

Review 5.  Fragile X syndrome.

Authors:  J P Phillips; G A Wilson
Journal:  Indian J Pediatr       Date:  1998 Mar-Apr       Impact factor: 1.967

6.  Screening for the fragile X syndrome among the mentally retarded: a clinical study. The Collaborative Fragile X Study Group.

Authors:  B B de Vries; S Mohkamsing; A M van den Ouweland; E Mol; K Gelsema; M van Rijn; A Tibben; D J Halley; H J Duivenvoorden; B A Oostra; M F Niermeijer
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

Review 7.  The fragile X syndrome.

Authors:  B B de Vries; D J Halley; B A Oostra; M F Niermeijer
Journal:  J Med Genet       Date:  1998-07       Impact factor: 6.318

8.  Fragile X checklists: A meta-analysis and development of a simplified universal clinical checklist.

Authors:  Toni Kasole Lubala; Aimé Lumaka; Gray Kanteng; Léon Mutesa; Olivier Mukuku; Stanislas Wembonyama; Randi Hagerman; Oscar Numbi Luboya; Prosper Lukusa Tshilobo
Journal:  Mol Genet Genomic Med       Date:  2018-04-06       Impact factor: 2.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.